½ÉÀå´ë»çÁõÈıºÇÐȸ 4th APCMS (Asia-Pacific CardioMetabolic Syndrome) Congress : 2021-04-24±³À°ÀÏÀÚ : 2021-04-24
±³À°Àå¼Ò : ¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ_ ¿ÀÇÁ¶óÀÎ: ÄÜ·¡µå ¼¿ï È£ÅÚ 5Ãþ ÆÄÅ©º¼·ë¿Ü 2°³·ë
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) 4th APCMS (Asia-Pacific CardioMetabolic Syndrome) CongressÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ
´ã´çÀÚ : ÀÌÈ¿Áø
¿¬¶ôó : 032-460-3663
À̸ÞÀÏ :
secret9595@naver.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 15 ½Ã°£ 22ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í »çÀüµî·Ï¸¸ ÁøÇà : M.D. / Ph.D. : 100,000 KRW ±âŸ : 30,000 KRW * ·Î±×ÀÎÀº Çà»ç ´çÀϸ¸ Á¢¼Ó °¡´ÉÇÕ´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë 1 08:10~08:40 Importance of Dyslipidemia Management in Patients with Endocrine Disorders : Focus on DM Patients Sung Hee Choi(Seoul National University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë 2 08:10~08:40 Interim Analysis of APOLLO Study: 1 Year Follow-up Results Seung-Woon Rha(Korea University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë 3 08:10~08:40 Optimal Anti-Hypertensives in CardioMetabolic Diseases with Hypertension Sang Min Park(Eulji University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©½ºÆ©µð¿À 08:10~08:40 Patient-Centered Approach to LDL-C Management Post-ACS Kyounghoon Lee(Gachon University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 09:00~09:20 Role of Vimentin in Atherosclerosis Young Mi Park(Ewha Womans University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 09:20~09:40 Deciphering the Role of Macrophages in Hyperlipidemic Cardiovascular Diseases Jae-Hoon Choi(Hanyang University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 09:40~10:00 ANGPTL4 in Cardiovascular Diseases Yong Sook Kim(Chonnam National University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 10:00~10:20 Rescue of Cardiac Remodeling in Diabetic Hearts by Activating Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 Jin Han(Inje University Korea)
Åä·Ð 04-24 ÆÄÅ©º¼·ë A 10:20~10:35 Discussion All Panelists()
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 09:00~09:20 Epicardial Adipose Tissue and Heart Seong-Mi Park(Korea University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 09:20~09:40 Diabetes and Heart Function Yong Li(Fudan University China)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 09:40~10:00 Characteristics of Koreans in Metabolic Syndrome Mi-Seung Shin(Gachon University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 10:00~10:20 Paradigm Shift in Anti-Diabetic Strategy: Focus on Cardiovascular Benefits Neng Dai(Fudan University China)
Åä·Ð 04-24 ÆÄÅ©º¼·ë B 10:20~10:35 Discussion All Panelists()
ÈÞ½Ä 04-24 10:35~10:55 Break ()
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 10:55~11:15 Medical Therapy Jon Suh(SoonChunHyang University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 11:15~11:35 PCI Cheol Ung Choi(Korea University Korea)
Åä·Ð 04-24 ÆÄÅ©º¼·ë A 11:35~11:55 Discussion All Panelists()
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 10:55~11:10 Integrated Management of Hypertension Complicated with Hyperlipidemia from China Tang Yida(Peking University Third Hospital China)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 11:10~11:25 New Strategies to Lipid Modification to Reduce Residual ASCVD Risk in 2021 Dao-Quan Peng(Central South University China)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 11:25~11:40 Triglyceride and Residual Risk of MACE Won Kim(Kyunghee University Korea)
Åä·Ð 04-24 ÆÄÅ©º¼·ë B 11:40~11:55 Discussion All Panelists()
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 12:05~12:30 Are Statins All the Same in Outcome and Safety for Asian? Ki-Hyun Jeon(Seoul National University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 12:05~12:30 Appropriate Statin Therapy for Primary Prevention Jong-Young Lee(Sungkyunkwan University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A,B 13:10~13:50 Lipoprotein(a) and Cardiovascular Diseases: Past, Present, and Future Kwang Kon Koh(Gachon University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 14:00~14:20 Metformin as Medications for Cardiometabolic Risk? Sangmo Hong(Hanyang University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 14:20~14:40 New PPARa Agonist Ichiro Sakuma(Health Science University of Hokkaido Japan)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 14:40~15:00 Fatty Liver and CVD Dong Hee Kim(University of California San Francisco USA)
Åä·Ð 04-24 ÆÄÅ©º¼·ë A 15:00~15:15 Discussion All Panelists()
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:00~14:12 Changes of Metabolic Syndrome Components According to the COVID-19 Pandemic in Stable Diabetes Mellitus Patients Minji Sohn(Seoul National University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:12~14:24 Connecting The Link Among Dental Problems, Atherosclerosis, Endocarditis, and Coronary Heart Disease Danan Budi Primadi(Universitas Islam Indonesia)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:24~14:36 Correlation between Brain Natriuretic Peptide (BNP) Level with Cardio Metabolic Factor Among Patients Acute Heart Failure with Diabetes Mellitus I Nyoman Indrawan Mataram(Klungkung District Hospital Indonesia)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:36~14:48 Long-Term Clinical Outcomes of Diabetic Patients with Negative Treadmill Stress Echocardiography: Worse Than Those of Non-diabetic Patients? Soyoung Yang(Kyung Hee University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:48~15:00 Association of Vitamin D Deficiency with Glycemic Control and Cardio-Metabolic Risk in Type 2 Diabetes Population Sushant Pokhrel(Manmohan Memorial Institute of Health Sciences Nepal)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 15:00~15:12 Echocardiography Segmentation Using Hierarchical Deep Learning Model for Early Screening Cardiac-Related Complications Cam Hao Hua(Kyung Hee University Korea)
ÈÞ½Ä 04-24 15:15~15:30 Break ()
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 15:30~16:00 Search for Novel HDL Biomarkers Arnold von Eckardstein(University of Zurich Switzerland)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 15:30~16:00 Association of COVID-19 with Cardiovascular and Metabolic Disorders Soo Lim(Seoul National University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 16:00~16:20 The Role of Aspirin in CVD Prevention Sunki Lee(Hallym University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 16:20~16:40 Deescalation of Antiplatelet Therapy in Patients with ACS KyungWoo Park(Seoul National University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 16:40~17:00 NOAC in Patients with CAD Yun Seok Choi(Catholic University Korea)
Åä·Ð 04-24 ÆÄÅ©º¼·ë A 17:00~17:15 Discussion All Panelists()
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:00~16:10 Solid Lipid Nanoparticle of Hesperidine Exerts Streptozotocin-Induced Cardiomyopathy via Inflammatory Pathway Vikas Kumar(Sam Higginbottom University of Agriculture India)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:10~16:20 Associations of Physical Activity and Lower Respiratory Tract Infection Outcomes in Patients with Cardiovascular Disease Mi-Hyang Jung(Hallym University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:20~16:30 Antiplatelet Therapy with Clopidogrel Considering with CYP2C19 Genetic Polymorphisms in Patients with Coronary Heart Disease after Coronary Artery Stenting Jamol Uzokov(Republican specialized scientific practical medical center Uzbekistan)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:30~16:40 Effects of Silver Nanoparticles on Renal Function in Fat-Fed and Streptozotocin-Treated Rats Pardeep Kumar(F H medical college India)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:40~16:50 Prevention of Gestational Diabetes before and during Pregnancy, Survey in Pune, India: Role of Daily Diet Leafy Green Vegetables, Fruit, and Milk. Sumit Rajput(Chaudhary Charan Singh University India)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:50~17:00 Amelioration in Glycosylated Hemoglobin (HbA1c) and Homeostasis Model Assessment (HOMA) of Pancreatic ¥â-cell from Alkaloids Rich Withania Somnifera through DPP-IV Inhibition in Type-2 Diabetic Rats: in-vitro, in-vivo, in-silico Anand-Krishna Singh(Shri Vaishnav Vidhyapeeth Vishvawidyalaya India)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 17:20~17:50 Controling Dyslipidemia and CV Risk with Atorvastatin and Ezetimibe Kyounghoon Lee(Gachon University Korea)
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 17:20~17:50 Focused on Right Target Patients, Candesartan/Rosuvastatin Jong-Chan Youn(Catholic University Korea)